Zomedica (ZOMDF) Non-Current Deferred Revenue (2021 - 2026)
Zomedica's Non-Current Deferred Revenue came in at $297,000 for Q3 2026, up 25.8% from $236,000 a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Non-Current Deferred Revenue (2021 - 2026) Analysis & Trends
At the end of FY2025, Zomedica's Non-Current Deferred Revenue was $232,000, up 5.9% from FY2024.
- Non-Current Deferred Revenue carries a four-year compound annual growth rate of 13.5% (FY2021 to FY2025).
- Going back by year, Non-Current Deferred Revenue was $219,000 in FY2024 (-13.1%), $252,000 in FY2023 (+38.5%), $182,000 in FY2022 (+30.0%) and $140,000 in FY2021.
- The Q3 2026 figure represents the highest quarterly Non-Current Deferred Revenue in data going back to Q4 2021.
- Year-over-year, Non-Current Deferred Revenue has increased for four consecutive quarters, with growth averaging 1.6% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deferred Revenue over five years came in Q2 2023 (growth of 80.7%), and the weakest in Q4 2024 (a decline of 13.1%).
- Business Quant data shows ZOMDF's Non-Current Deferred Revenue at $294,000 (Q2 2026), $273,000 (Q1 2026) and $232,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 297,000.00 |
| Jun 30, 2026 | 294,000.00 |
| Mar 31, 2026 | 273,000.00 |
| Dec 31, 2025 | 232,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 251,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Dec 31, 2023 | 252,000.00 |
| Sep 30, 2023 | 270,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 213,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 140,000.00 |
API Access
Zomedica Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();